Contract Insights

The April 2025 Presidential Executive Order, “Lowering Drug Prices by Once Again Putting Americans First,” brings forth a restructuring of the regulatory landscape for pharmaceutical and healthcare entities. These organizations are urgently analyzing current contracts and generating new agreements to comply with impending federal reforms aimed at reducing medication costs. In the heat of this scramble, powerful pharma contract management and healthcare agreement software solutions have gone from optional resources to essential assets for legal and procurement teams.

To that end, let's examine how integrated pharma contract management, healthcare agreement, and hospital procurement software solutions can help organizations easily navigate new drug pricing reforms.

The Physician Payments Sunshine Act was passed by the United States in 2010 in an effort to increase the transparency of the fiscal relationships of drug manufacturers, medical device producers, and biological and medical supplies companies with health care providers.  The institution of the Sunshine Act demanded pharmaceutical organizations with relationships to Medicare, Medicaid, and the State Children’s Health Insurance Program (SCHIP) to collect and track data relating to their agreements with entities such as physicians and teaching hospitals.